InvestorsHub Logo
Followers 65
Posts 23901
Boards Moderated 0
Alias Born 11/23/2016

Re: XenaLives post# 268076

Monday, 08/31/2020 11:50:09 AM

Monday, August 31, 2020 11:50:09 AM

Post# of 462259
How do we get to understand if a drug has:
long term safety for most
Rare side effects for some
Efficacy for all, or
Efficacy for some based on what

without controlled clinical trials and long term use?

Once we have sufficiently varied and large enough natural history cohorts in approved databases for many different diseases great. We don’t yet!

Until then hard to see how we could do without randomised controlled trials and not least in rare diseases.

Just letting biotech and pharma companies loose e.g. selling their wares under the auspices of say P4 trials or card blanche provisional approvals would be a free for all snake oil market.

And no we are far from understanding human biology and biochemistry well enough and with complex and powerful enough compute power to simply simulate our way to new perfect drugs in silico.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News